Literature DB >> 12611275

New propargyl thioquinolines--synthesis, antiproliferative activity in vitro and structure-activity relationships.

S Boryczka1, J Wietrzyk, A Nasulewicz, M Pełczyńska, A Opolski.   

Abstract

The series of the propargyl thioquinolines has been prepared on the basis of the reaction of thioquinanthrene (1) (1,4-dithiino[2,3-c:5,6-c']-diquinoline) with sodium alkoxides. Some of these compounds have revealed good antiproliferative activity in vitro against the cells of human and murine cancer lines. 13C NMR spectra were measured for the studied compounds to examine the electronic properties-activity relationships. A regression study on 10 compounds showed a linear correlation of antiproliferative activity with electronic properties, expressed as the 13C NMR chemical shift for C-4 carbon atom (R2 = 0.97). It was found that compounds with chemical shift for C-4 value falling in the range of 135-140 ppm exhibited significant antiproliferative activity, while compounds which possess moderate or low activity are located in the range 140-165 ppm. This finding leads to the expectation that the antiproliferative activity of propargyl thioquinolines can be predicted using the 13C NMR chemical shift value of their C-4 carbon atom.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12611275

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Synthesis and in vitro antiproliferative activity of novel (4-chloro- and 4-acyloxy-2-butynyl)thioquinolines.

Authors:  Stanisław Boryczka; Wojciech Mól; Magdalena Milczarek; Joanna Wietrzyk; Ewa Bębenek
Journal:  Med Chem Res       Date:  2010-11-17       Impact factor: 1.965

2.  Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives.

Authors:  Krzysztof Marciniec; Bartosz Pawełczak; Małgorzata Latocha; Leszek Skrzypek; Małgorzata Maciążek-Jurczyk; Stanisław Boryczka
Journal:  Molecules       Date:  2017-02-16       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.